MARKET

LCTX

LCTX

Lineage Cell The
AMEX
0.7719
-0.0481
-5.87%
After Hours: 0.7994 +0.0275 +3.56% 16:19 11/20 EST
OPEN
0.8100
PREV CLOSE
0.8200
HIGH
0.8385
LOW
0.7700
VOLUME
2.04M
TURNOVER
--
52 WEEK HIGH
1.985
52 WEEK LOW
0.7697
MARKET CAP
195.26M
P/E (TTM)
124.50
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at LCTX last week (1109-1113)?
Weekly Report · 4d ago
Lineage Cell Therapeutics Earnings Call Signals Portfolio Expansion
TipRanks · 5d ago
Analysts Offer Insights on NA Companies: Pelthos Therapeutics (PTHS) and Lineage Therap (LCTX)
TipRanks · 11/13 14:10
Lineage Cell Therapeutics to Buy NeuroAirmid for $2.4M
Dow Jones · 11/12 21:57
Lineage Therapeutics Acquires NeuroAirmid, Expanding Cell Therapy Pipeline
TipRanks · 11/12 21:45
Lineage Cell (LCTX) Reports Q3 Loss, Misses Revenue Estimates
NASDAQ · 11/12 21:25
*Lineage Cell Therapeutics Paid NeuroAirmid Investors Approximately Half in Cash, Half in Shrs of Lineage Common Stk >LCTX
Dow Jones · 11/12 21:18
*Lineage Cell Therapeutics Upon Closing Lineage Paid Approximately $4. M to NeuroAirmid Investors>LCTX
Dow Jones · 11/12 21:17
More
About LCTX
Lineage Cell Therapeutics, Inc. is a clinical-stage biotechnology company developing cell replacement therapies to treat serious medical conditions. The Company programs are based on a cell-based technology platform, AlloSCOPE (Allogeneic, Scalable, Consistent, Off-the-shelf, Pluripotent Cell Engineering), and associated development and manufacturing capabilities. AlloSCOPE platform, develops, manufactures, and tests specialized human cells with anatomical and physiological functions similar or substantially identical to cells found naturally in the human body. The Company's pipeline includes OpRegen, HUNT1, OPC1, ReSonance, COR1, ILT1, PNC1, and RND1. OpRegen, an allogeneic retinal pigment epithelial (RPE) cell replacement therapy for the treatment of geographic atrophy (GA) secondary to age-related macular degeneration (dry-AMD), HUNT1, a pluripotent stem cell derived, neural cell therapy in Phase 1b/2a development for the treatment of Huntington’s Disease.

Webull offers Lineage Cell Therapeutics Inc stock information, including AMEX: LCTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LCTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LCTX stock methods without spending real money on the virtual paper trading platform.